Re: &quot;Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients,&quot; by Kumar et al.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Assay Drug Dev Technol

Title: Assay and drug development technologies

Publisher: Mary Ann Liebert Inc

ISSN (Electronic): 1557-8127

ISSN (Print): 1540-658X

Publication date (Electronic): Oct 2021

Volume: 19

Issue: 7

Affiliations

[1 ] Molecular Immunogenetics Group, National Institute of Immunology, New Delhi, India.

Article

DOI: 10.1089/adt.2020.1002

PubMed ID: 34463124

SO-VID: 90d1c46f-bf80-4cd6-a712-588c49f76227

History

Data availability:

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Re: "Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients," by Kumar et al.

Read this article at